Equity Overview
Price & Market Data
Price: $1.80
Daily Change: -$0.10 / 5.56%
Daily Range: $1.80 - $1.85
Market Cap: $23,894,400
Daily Volume: 5,617
Performance Metrics
1 Week: -8.92%
1 Month: 18.75%
3 Months: -1.04%
6 Months: -52.50%
1 Year: -52.50%
YTD: -13.64%
Company Details
Employees: 2
Sector: Biotechnology
Industry: AMEX
Country:
Details
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company has a strategic alliance with University of Alabama for the development of ai² future labs program. The company was incorporated in 2020 and is based in Matawan, New Jersey.